Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Analysis of a Finnish family confirms RHBDF2 mutations as the underlying factor in tylosis with esophageal cancer.

Saarinen S, Vahteristo P, Lehtonen R, Aittomäki K, Launonen V, Kiviluoto T, Aaltonen LA.

Fam Cancer. 2012 Sep;11(3):525-8. doi: 10.1007/s10689-012-9532-8.

PMID:
22638770
2.

RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome.

Blaydon DC, Etheridge SL, Risk JM, Hennies HC, Gay LJ, Carroll R, Plagnol V, McRonald FE, Stevens HP, Spurr NK, Bishop DT, Ellis A, Jankowski J, Field JK, Leigh IM, South AP, Kelsell DP.

Am J Hum Genet. 2012 Feb 10;90(2):340-6. doi: 10.1016/j.ajhg.2011.12.008. Epub 2012 Jan 19.

3.

[RHBDF2 mutations in familial palmoplantar keratoderma associated with tylosis oesophageal cancer].

Dereure O.

Ann Dermatol Venereol. 2012 Aug-Sep;139(8-9):605-6. doi: 10.1016/j.annder.2012.04.001. Epub 2012 May 15. French. No abstract available.

PMID:
22963978
4.

Envoplakin, a possible candidate gene for focal NEPPK/esophageal cancer (TOC): the integration of genetic and physical maps of the TOC region on 17q25.

Risk JM, Ruhrberg C, Hennies H, Mills HS, Di Colandrea T, Evans KE, Ellis A, Watt FM, Bishop DT, Spurr NK, Stevens HP, Leigh IM, Reis A, Kelsell DP, Field JK.

Genomics. 1999 Jul 15;59(2):234-42.

PMID:
10409435
5.

Tylosis with oesophageal cancer: Diagnosis, management and molecular mechanisms.

Ellis A, Risk JM, Maruthappu T, Kelsell DP.

Orphanet J Rare Dis. 2015 Sep 29;10:126. doi: 10.1186/s13023-015-0346-2. Review.

6.

Novel microsatellite markers and single nucleotide polymorphisms refine the tylosis with oesophageal cancer (TOC) minimal region on 17q25 to 42.5 kb: sequencing does not identify the causative gene.

Langan JE, Cole CG, Huckle EJ, Byrne S, McRonald FE, Rowbottom L, Ellis A, Shaw JM, Leigh IM, Kelsell DP, Dunham I, Field JK, Risk JM.

Hum Genet. 2004 May;114(6):534-40. Epub 2004 Mar 9.

PMID:
15007728
7.

Tissue-specific role of RHBDF2 in cutaneous wound healing and hyperproliferative skin disease.

Hosur V, Lyons BL, Burzenski LM, Shultz LD.

BMC Res Notes. 2017 Nov 7;10(1):573. doi: 10.1186/s13104-017-2899-8.

8.

The tylosis esophageal cancer (TOC) locus: more than just a familial cancer gene.

Risk JM, Mills HS, Garde J, Dunn JR, Evans KE, Hollstein M, Field JK.

Dis Esophagus. 1999;12(3):173-6.

PMID:
10631907
9.

Candidate susceptibility variants for esophageal squamous cell carcinoma.

Donner I, Katainen R, Tanskanen T, Kaasinen E, Aavikko M, Ovaska K, Artama M, Pukkala E, Aaltonen LA.

Genes Chromosomes Cancer. 2017 Jun;56(6):453-459. doi: 10.1002/gcc.22448. Epub 2017 Apr 3.

PMID:
28165652
10.

RHBDF2-Regulated Growth Factor Signaling in a Rare Human Disease, Tylosis With Esophageal Cancer: What Can We Learn From Murine Models?

Hosur V, Farley ML, Low BE, Burzenski LM, Shultz LD, Wiles MV.

Front Genet. 2018 Jul 4;9:233. doi: 10.3389/fgene.2018.00233. eCollection 2018.

11.

Loss of heterozygosity in sporadic oesophageal tumors in the tylosis oesophageal cancer (TOC) gene region of chromosome 17q.

von Brevern M, Hollstein MC, Risk JM, Garde J, Bennett WP, Harris CC, Muehlbauer KR, Field JK.

Oncogene. 1998 Oct 22;17(16):2101-5.

12.

An investigation of the tylosis with oesophageal cancer (TOC) locus in Iranian patients with oesophageal squamous cell carcinoma.

Shahabi M, Noori Daloii MR, Langan JE, Rowbottom L, Jahanzad E, Khoshbin E, Taghikhani M, Field JK, Risk JM.

Int J Oncol. 2004 Aug;25(2):389-95.

PMID:
15254736
13.

Tylosis esophageal cancer locus on chromosome 17q25.1 is commonly deleted in sporadic human esophageal cancer.

Iwaya T, Maesawa C, Ogasawara S, Tamura G.

Gastroenterology. 1998 Jun;114(6):1206-10.

PMID:
9609757
14.

Down-regulation of the cytoglobin gene, located on 17q25, in tylosis with oesophageal cancer (TOC): evidence for trans-allele repression.

McRonald FE, Liloglou T, Xinarianos G, Hill L, Rowbottom L, Langan JE, Ellis A, Shaw JM, Field JK, Risk JM.

Hum Mol Genet. 2006 Apr 15;15(8):1271-7. Epub 2006 Mar 1.

PMID:
16510494
15.

Infrequent mutation of the human envoplakin gene is closely linked to the tylosis oesophageal cancer locus in sporadic oesophageal squamous cell carcinomas.

Iwaya T, Maesawa C, Kimura T, Ogasawara S, Ikeda K, Kimura Y, Noda Y, Ishida K, Sato N, Saito K, Masuda T.

Oncol Rep. 2005 Apr;13(4):703-7.

PMID:
15756445
16.

Tylosis A with squamous cell carcinoma of the oesophagus in a Spanish family.

Varela AB, Blanco Rodríguez MM, Boullosa PE, Silva JG.

Eur J Gastroenterol Hepatol. 2011 Mar;23(3):286-8. doi: 10.1097/MEG.0b013e328344042d.

PMID:
21285883
17.

Characterization of a 500 kb region on 17q25 and the exclusion of candidate genes as the familial Tylosis Oesophageal Cancer (TOC) locus.

Risk JM, Evans KE, Jones J, Langan JE, Rowbottom L, McRonald FE, Mills HS, Ellis A, Shaw JM, Leigh IM, Kelsell DP, Field JK.

Oncogene. 2002 Sep 12;21(41):6395-402.

18.

To B or not to B: is tylosis B truly benign? Two North American genealogies.

Maillefer RH, Greydanus MP.

Am J Gastroenterol. 1999 Mar;94(3):829-34.

PMID:
10086674
19.

Close mapping of the focal non-epidermolytic palmoplantar keratoderma (PPK) locus associated with oesophageal cancer (TOC).

Kelsell DP, Risk JM, Leigh IM, Stevens HP, Ellis A, Hennies HC, Reis A, Weissenbach J, Bishop DT, Spurr NK, Field JK.

Hum Mol Genet. 1996 Jun;5(6):857-60.

PMID:
8776604
20.

Tylosis oesophageal cancer mapped.

Risk JM, Field EA, Field JK, Whittaker J, Fryer A, Ellis A, Shaw JM, Friedmann PS, Bishop DT, Bodmer J, et al.

Nat Genet. 1994 Dec;8(4):319-21. No abstract available.

PMID:
7534553

Supplemental Content

Support Center